Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
19,093
Sort by:
Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Sterile Injectables CDMO Market Trends The global sterile injectables CDMO market size was estimated at USD 4.25 billion in 2024 an...
January 2025
180 pages
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2025-2033
US$ 2,999.00
The global generic drugs market size reached USD 389.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 674.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.66% dur...
January 2025
136 pages
Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceutical Industry, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2025-2033
US$ 2,999.00
The global medical cannabis market size reached USD 37.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 68.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.1% dur...
January 2025
125 pages
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2025-2033
US$ 2,999.00
The global travel vaccines market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.36% duri...
January 2025
129 pages
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
US$ 2,999.00
The global specialty generics market size reached USD 81.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 178.6 Billion by 2033, exhibiting a growth rate (CAGR) of 9.1%...
January 2025
127 pages
Europe Highly Potent API Market By Type (Innovative High-Potency APIs and Generic High-Potency APIs), By Type of Synthesis (Synthetic and Biological), By Therapeutic Area (Oncology, Immunology, Hormonal Disorders, Infectious Diseases, and Others), By Type of Manufacturing (In-House and Outsourced), By End User (Biopharmaceutical & Life Science Companies, Contract Drug Manufacturing Organizations, and Research Institutions), By Country, Competition, Forecast and Opportunities, 2020-2030F
US$ 4,000.00
Europe Highly Potent API Market was valued at USD 6.43 Billion in 2024 and is expected to reach USD 11.02 Billion by 2030 with a CAGR of 9.36% during the forecast period. The Europe Highly Potent Acti...
January 2025
133 pages
Saudi Arabia Antiviral Drugs Market, By Type (Branded, Generics), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Antiviral Drugs Market was valued at USD 505.15 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 2.39% through 2030. The antiviral drugs m...
January 2025
82 pages
Saudi Arabia Dermatological Drugs Market, By Therapy (Acne, Psoriasis, Rosacea, Alopecia, Others), By Type (Prescription, Over the counter (OTC)), By Route of Administration (Topical Administration, Oral Administration, Parenteral Administration), By Drug Class (Corticosteroids, Retinoids, Antibiotics, Antifungals, Calcineurin Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Dermatological Drugs Market was valued at USD 331.45 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.85% through 2030. The dermatol...
January 2025
82 pages
Saudi Arabia Pharmaceutical CRO Market, By Type (Drug Discovery, Pre-Clinical, Clinical), By Molecular Type (Small Molecules, Large Molecules), By Service (Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Biostatistics, Investigator Payments, Laboratory, Patient And Site Recruitment, Technology, Others), By Therapeutics Area (Oncology, CNS Disorders, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Respiratory Diseases, Diabetes, Ophthalmology, Pain Management, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Pharmaceutical CRO Market was valued at USD 236.45 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.45% through 2030. The pharmaceut...
January 2025
80 pages
Saudi Arabia Topical Drugs Market, By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), By Type (Semi-solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), By End User (Home Care Settings, Hospitals & Clinics, Burn Centers, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Topical Drugs Market was valued at USD 850.82 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 4.75% through 2030. A large segment of the...
January 2025
82 pages
Vietnam Ophthalmic Drugs Market By Drug Class (Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma, Gene & Cell Therapy, and Others), By Drug Disease (Dry Eye, Allergies, Glaucoma Infection, Retinal Disorders, Uveitis, Others), By Route Of Administration (Topical, and Local Ocular), By Dosage Type (Gels, Eye solutions & suspensions, Capsules & Tablets, Eye drops, and Ointments), By Region, Competition, Forecast and Opportunities, 2020-2030F
US$ 3,500.00
Vietnam Ophthalmic Drugs Market was valued at USD 478.32 Million in 2024 and is expected to reach USD 824.18 Million by 2030 with a CAGR of 9.45% during the forecast period. The Vietnam ophthalmic dru...
January 2025
83 pages
Global Clinical Trials Support Services Market Size Study, by Service (Clinical Trial Site Management, Patient Recruitment Management, Data Management, Administrative Staff, IRB, Others), Phase (Phase I, Phase II, Phase III, Phase IV), Sponsor (Pharmaceutical & Biopharmaceutical, Medical Devices, Others), and Regional Forecasts 2022-2032
US$ 3,218.00
The Global Clinical Trials Support Services Market, valued at approximately USD 21.3 million in 2023, is projected to expand significantly, growing at a CAGR of 8.00% during the forecast period 2024-2...
January 2025
285 pages
Global Pharmaceutical Ethanol Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Pharmaceutical Ethanol, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...
January 2025
134 pages
